BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Alnylam Pharmaceuticals, Inc. (NQ: ALNY)
52.78 USD  -1.54 (-2.84%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 24, 2014  /  Add to My Watchlist      
(ALNY) Community Analysis from
April 24, 2014
(Stock Blog Hub, 1/9/13)
Alnylam Pharmaceuticals Inc (ALNY) recently announced its goal for the next two years (2013 and 2014) regarding its key “Alnylam 5x15” pipeline and partner...(read more)
(Stock Blog Hub, 10/8/12)
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently announced the pricing of its initial...(read more)
Courtesy of Benzinga. ekmira Pharmaceuticals Corporation (Nasdaq: TKMR) disclosed that Alnylam Pharmaceuticals, Inc. filed a...(read more)
Alnylam Pharmaceuticals (ALNY) Company Overview

There is no analysis for ALNY yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here